News dal mondo
16
Lug
EU DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health
DG SANTE and the European Medicines Agency (EMA) have signed a Working Arrangement with New Zealand Ministry of Health (incorporating the New Zealand Medicines and Medical Devices Safety Authority - Medsafe) this week, to strengthen collaboration and exchange of information on medicinal products. The agreement was signed by DG SANTE Director-General Sandra Gallina and EMA Executive Director Emer Cooke. Director-General Audrey Sonerson signed for the New Zealand Ministry of Health. The purpose of this Working Arrangement is to strengthen cooperation between signatories across a range of areas in public health, while promoting the timely, secure exchange of information. Deliverables from the Arrangement will include: The Arrangement will run from 6 July 2026 [European Commission]
15
Lug
Riforma farmaceutica. Via libera della Commissione Sanità del Senato
Le poche modifiche approvate non cambiano l'impianto della riforma. L’articolo 3 a...
14
Lug
China NMPA conducts management review of QMS for regulation of vaccine and drug GMP compliance
The National Medical Products Administration (NMPA) conducted its 2025 annual management review of the...
14
Lug
AIFA: “Cerca un farmaco”: disponibili nuove informazioni sullo stato di commercializzazione dei medicinali
Il servizio di informazione sui medicinali ad uso umano autorizzati in Italia “AIFA Medicinali”,...
13
Lug
ECHA: riforma dell’Agenzia europea delle sostanze chimiche
The Council of the European Union and the European Parliament have reached a provisional agreement on...
le ultime news
27 Mag
Generics drugmaker Sandoz calls for EU to probe alleged China dumping
22 Mag
Min. Salute - Strategia nazionale sulla salute e sicurezza sul lavoro, approvata in Conferenza Stato-Regioni
22 Mag
Testo unico farmaceutica, i lavori entrano nel vivo: a breve l’esame dei 302 emendamenti
18 Mag
AIFA Sistema informatico Workflow Officine Materie Prime - Ulteriore Aggiornamento tecnico 18 maggio 2026
15 Mag
US FDA’s New AI-Informed Inspection Pilot and What It Means for Industry
15 Mag
EU Regulators discuss new pharma legislation, AI, and more
15 Mag
US FDA official details top observations from QMSR inspections
15 Mag
European Commission outlines plans to mobilize EMA to diversify supply chains